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ABSTRACT 
Nephropathic cystinosis, a lysosomal storage disease caused by mutations in the CTNS gene 
encoding the lysosomal cystine transporter cystinosin, is characterized by generalized 
proximal tubule dysfunction that progresses, if untreated, to end-stage renal disease. The 
pathogenesis of defective proximal tubule cellular transport in nephropathic cystinosis 
remains unclear. 
We characterized in detail a new line of C57BL/6 Ctns-/- mice and analyzed endocytic uptake, 
lysosome function, and dedifferentiation/proliferation markers using primary cultures of 
proximal tubule epithelial cells derived from Ctns-/- and Ctns+/+ littermates. Metabolic studies 
revealed that Ctns-/- mice show a progressive proximal tubule dysfunction characterized by 
low-molecular-weight proteinuria, glucosuria and phosphaturia, before structural damage and 
in absence of renal failure. These changes are related to decreased expression of the multi-
ligand receptors megalin and cubilin and to increased dedifferentiation (ZONAB 
transcriptional factor) and proliferation (PCNA and Cyclin D1) rates. Studies on primary 
cultured proximal tubule cells derived from Ctns-/- kidneys confirmed cystin overload, with 
accumulation of enlarged, dysfunctional lysosomes and reduced expression of endocytic 
receptors reflected by decreased uptake of specific ligands. These changes were related to a 
loss of integrity of tight junctions with a nuclear translocation of ZONAB and increased 
proliferation, as observed in Ctns-/- kidneys. These data reveal that the absence of cystinosin 
in proximal tubule cells triggers aberrations of the endolysosomal compartment, transport 
defects and dedifferentiation appearing in the early stage of nephropathic cystinosis.  
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INTRODUCTION 
The proximal tubules (PT) of the kidney reabsorb the bulk of filtered solutes and water, 
through polarized transport systems which reflect terminal differentiation of the epithelial 
cells. Global dysfunction of these transport processes, which is referred to as renal Fanconi 
syndrome, leads to the excessive urinary loss of solutes (1). In turn, solute losses may cause 
dehydration and electrolyte imbalance, rickets, muscular weakness, growth retardation, and 
progressive renal failure. Cystinosis is the most frequent form of congenital renal Fanconi 
syndrome in children (2). The disease is caused by autosomal recessive mutations in the 
CTNS gene that encodes the lysosomal transporter cystinosin (3,4). Loss of cystinosin 
function results in the accumulation of cystine inside lysosomes and formation of cystine 
crystals in multiple organs including the kidney. Nephropathic cystinosis, the most severe and 
frequent form of cystinosis, is characterized by a progressive dysfunction of proximal tubule 
cells that appears by 6 to 12 months of age. In absence of treatment with cysteamine, end-
stage renal disease is reached around 10 years of age (2).  
 The pathogenesis of defective proximal tubule transport in NC remains unclear (5). 
Depletion of intracellular ATP, abnormalities in cellular glutathione (GSH) levels affecting 
mitochondrial function and redox state, increased apoptosis, as well as autophagy and 
mitophagy have been described in various model systems (5-7). Although these events may 
coexist at various phases of cell damage, their direct impact on the early defects in transport 
causing renal Fanconi syndrome is not established. Similarly, the involvement of the multi-
ligand receptors megalin and cubilin in the pathogenesis of cystinosis remains unclear. 
Studies in human biopsy material revealed that the receptors were normally expressed in 
proximal tubule cells (8). Albumin uptake was not affected in clonal cells derived from the 
urine of cystinotic patients (6), suggesting that the mechanism of low-molecular-weight 
(LMW) proteinuria may be different in NC than other types of proximal tubule dysfunction 
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(5). Informations on time-course and relative importance of tubular transport defects before 
onset of renal failure in NC are also lacking, and the link between such defective transport 
processes, residual cystinosin activity and lysosomal cystine accumulation remains uncertain. 
Furthermore, treatment with cysteamine, which depletes lysosomal cystine content, does not 
improve proximal tubule dysfunction even when started early in life (2,9).  
 The difficulty to address mechanisms of proximal tubule dysfunction in NC is 
explained at least in part by limitations of the cellular and animal models used thus far (5). 
Data obtained either on animal models with incomplete phenotype, on non-renal or non-
epithelial cell types, or on clones of transformed cells isolated from urine are difficult to 
analyze as these cell types may lack essential functions of native proximal tubule cells. Renal 
biopsy material, usually obtained in case of complications or at an advanced disease stage, is 
of limited value. Until recently, no mouse model mimicking the renal Fanconi syndrome and 
renal disease associated with cystinosis was available. The first Ctns-null mouse model, 
obtained on a mixed 129/Sv x C57BL/6 genetic background, showed an accumulation of 
cystine in the kidney and all organs tested but failed to recapitulate the generalized proximal 
tubule dysfunction that is present in NC patients. Recently, a congenic C57BL/6 Ctns line 
showed accumulation of cystin in the kidney, with signs of tubulopathy, severe histological 
lesions and chronic renal failure from 10 to 18 months of age (10). We have now used this 
Ctns mouse model to investigate the mechanisms underlying specific transport defects in 
cystinosis, based on in vivo, ex vivo and in vitro methods. Our results reveal that the absence 
of cystinosin in proximal tubule cells triggers an early chain of events leading to 
endolysosomal dysfunction, transport defects and dedifferentiation appearing before structural 
damage and renal failure.  
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RESULTS 
1. Ctns mice: Progression of proximal tubule dysfunction. 
We first used the Ctns-/- mice to characterize the time-course and progression of the renal 
phenotype before the onset of renal failure (Fig.1, Table 1). As compared to wild-type 
littermates, Ctns-/- mice showed growth retardation and progressive manifestations of renal 
Fanconi syndrome, including low-molecular-weight (LMW) proteinuria from the age of 12 
weeks, followed by polyuria, phosphaturia and glucosuria from 18 weeks. Generalized 
proximal tubule dysfunction was observed at 24 weeks, with inappropriate loss of megalin 
and cubilin ligands, including vitamin D binding protein, transferrin, and procathepsin B, in 
absence of renal failure (evidenced by similar levels of creatinine clearance and BUN) (Fig. 
1A,B; Table 1).  
Typical features of nephropathic cystinosis were observed in the Ctns-/- kidneys at this stage: 
(i) focal atrophy of juxta-glomerular proximal tubules (“swan neck” lesions), restricted to ~ 
5% of the nephrons whereas the renal parenchyma was looking strictly normal (Fig. 1C); and 
(ii) lysosomal accumulation of cystine crystals in proximal tubule cells, as shown by 
electronic microscopy (Fig. 1C) and cystine assay in kidney cortex (Fig. 1D). As expected, 
signs of renal failure were detected in Ctns mice aged >30 weeks, with increased plasma 
levels of creatinine and BUN (data no shown). 
 
2. Abnormal expression of transporters and receptors in Ctns-/- kidneys. 
Having established the time-course of renal Fanconi syndrome in this model, we investigated 
the expression of transporters and receptors in Ctns-/- kidneys, focusing at 24 weeks of age 
when proximal tubule dysfunction is observed while renal tissue is preserved. These studies 
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revealed that the urinary loss of solutes is associated with decreased expression of specific 
transporters (including NaPi-IIa and SGLT2) and receptors (megalin/cubilin) in Ctns-/- 
kidneys, at the mRNA and protein level (Fig. 2A-C). The decreased expression was selective, 
as other components of proximal tubule cells such as the water channel AQP1, the endocytic 
catalyst Rab5a and the brush border component CD13 (aminopeptidase N) were unaffected 
(Fig. 2A,B). These data reveal that the early phase of cystinosis is characterized by a specific 
transport defect in vivo, caused by the loss of peculiar receptors and transporters in proximal 
tubule cells. 
 
3. Defective endocytosis and lysosomal function in proximal tubule cells derived from Ctns-/- 
kidneys. 
In order to confirm the cell-specificity of the endocytic defect observed in vivo, we developed 
primary cultures of proximal tubule cells from microdissected proximal tubule segments of 
Ctns-/- mice aged 20 weeks (Fig. 3). It has been shown previously that, when grown on 
permeable supports, these primary cultured cells preserve their differentiation and polarized 
transport processes (11). Our functional studies showed that primary cultured proximal tubule 
cells obtained from Ctns-/- kidneys show defective endocytosis as evidenced by a ∼70% 
reduction  in albumin uptake as compared to Ctns+/+ cells (23 ± 5.0 vs. 75 ± 7.1 ng/µg 
protein.15min, n=5 pairs, P<0.0005) (Fig. 3A,B). These changes were associated with a 
decreased expression of megalin and cubilin receptors, as well as of the apical transporters 
NaPi-IIa and SGLT2 (Fig. 3C-E). 
Since nephropathic cystinosis is characterized by lysosomal dysfunction in vivo, we next 
investigated whether an impairment of lysosomal function could be associated with defective 
endocytosis in proximal tubule cells derived from 20-week old Ctns mice. As compared with 
7 
 
Ctns+/+ control cells, the Ctns-/- cells showed a strong intracellular accumulation of cystine 
(Fig. 4A), as well as the concentration of all lysosomal related vesicles into fewer and larger 
lysosomes that expressed late endosomal/lysosomal markers lysosome-associated membrane 
protein 1 (LAMP1) or LAMP2 (Fig. 4B). Similar results were obtained in these cells using 
cathepsin D as a luminal marker (Fig. 4B). Importantly, confocal microscopy revealed that 
LAMP1 positive lysosomes were dispersed widely throughout the cytosol in control cells, 
whereas lysosomes aggregated predominantly in the perinuclear region of cystinosin-depleted 
cells (Fig. 4B).  
Having shown that the loss of cystinosin function results in an accumulation of enlarged 
lysosomes in proximal tubule cells, we next examined whether the lysosomal enzymatic 
degradation capacity was affected. Dynamic and quantitative analysis of lysosomal enzymatic 
activity was performed by monitoring the temporal response of cathepsin B activity in live 
cells by Fluorescence Recovery After Photo-bleaching (FRAP) experiments. To this end, 
living primary cultured proximal tubule cells from Ctns kidneys were loaded with the 
membrane-permeable substrate, Magic Red that upon cathepsin B cleavage, releases 
fluorescent peptides inside lysosomes. In control Ctns+/+ cells, the photo-bleaching of Magic 
Red positive lysosomes was followed by a rapid (τ1/2 =47 sec) and substantial (60%) recovery 
of the initial fluorescence (Fig. 4F, upper panels). Conversely, in Ctns-/- cells, the fluorescence 
recovery was slower (τ1/2 =60 sec) and smaller (20% recovery of the initial fluorescence) (Fig. 
4F, lower panels). To confirm the specificity of the Magic Red tracer, we incubated Ctns+/+ 
cells with leupeptin so to block specifically the cathepsin B activity (Fig. 4G). The treatment 
with leupeptin suppressed the release of fluorescent peptides, indicating that Magic Red 
hydrolysis was cathepsin B dependent.  
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4. Dedifferentiation, proliferation and defective transcriptional program in cystinosis. 
We next investigated potential mechanisms for the loss of proximal tubule receptors and 
transporters expression in the early phase of cystinosis. By analogy with other congenital or 
acquired disorders of the proximal tubule, we reasoned that such changes could reflect a 
dedifferentiated state of the epithelial cells due to a specific transcriptional program (12,13). 
The 20-week old Ctns-/- kidneys showed a marked increase in the expression of the 
proliferation markers PCNA and cyclin D1 (Fig. 5A,B). Both molecules are classical targets 
of the Y-box transcription factor ZONAB (14), which showed a nuclear translocation (Fig. 
5A) and co-enrichment with PCNA in nuclear extracts of Ctns-/-kidneys (Fig. 5C). The fact 
that ZONAB drives proliferation and directly represses megalin and cubilin in proximal 
tubule cells (13) could explain the functional changes observed in Ctns-/- mice.  
The latter hypothesis was substantiated in proximal tubule cells obtained from Ctns mice (Fig. 
6). The Ctns-/- cells showed increased proliferation (Fig. 6A), and a major nuclear 
translocation of ZONAB together with PCNA expression (Fig. 6B,C). Since the mRNA 
expression of ZONAB is unchanged in these cells, we tested whether the increased ZONAB 
activity could reflect a loss of tight junction integrity (14). The primary cultured proximal 
tubule cells obtained from Ctns-/- kidneys showed a loss of tight junction integrity as 
evidenced by a loss of signal for ZO1 (Fig. 6D,E) and a reduction in the transepithelial 
resistance (Rt: 26.2 ± 2.3 vs. 58.4 ± 2.7 Ω/cm2) and current (Isc: 5.42 ± 0.76 vs. 14.2 ± 0.63 
µA/cm2) compared to control cells  (Fig. 6F). 
Taken together, these data suggest that the early phase of nephropathic cystinosis is 
characterized by specific transcriptional events modifying the expression of key 
transporters/receptors in proximal tubule cells, with a phenotype of dedifferentiation and 
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proliferation. These changes are observed both in vivo and in vitro, and occur before any 
visible histological lesion of the cystinosis kidneys.  
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DISCUSSION 
In this study, we show that invalidation of cystinosin in mouse induces a progressive 
dysfunction of the proximal tubule with LMW proteinuria, glucosuria and phosphaturia, 
before structural damage and in absence of renal failure. These changes are related to 
decreased expression of megalin and cubilin receptors and of specific transporters, in parallel 
with lysosomal dyfunction, dedifferentiation and increased proliferation of proximal tubule 
cells. Studies on primary cultures of differentiated proximal tubule cells confirmed both the 
defective endocytosis and the impaired lysosomal function, involving a loss of integrity of 
tight junctions and an abnormal transcription program involving ZONAB. These data reveal 
that the loss of cystinosin function in proximal tubule cells triggers an early chain of events 
leading to dedifferentiation and transport defects, before structural damage. Furthermore, like 
other types of lysosomal storage disorders, cystinosis is associated with aberrations of the 
endolysosomal compartment (16,17).  
In addition to glucose, amino acids, phosphate and other ions, a significant amount of 
filtered albumin and LMW plasma proteins is continuously reabsorbed by the epithelial cells 
lining the proximal tubule. The uptake of LMW proteins by these cells essentially involves 
receptor-mediated endocytosis, while fluid-phase capture can be considered as quantitatively 
negligible. The process essentially requires two multiligand receptors, megalin and cubilin, 
and the cooperating protein amnionless that are expressed at the brush border of the cells (18). 
Ligand binding and interactions between both receptors induce their internalization into 
coated vesicles and their subsequent delivery to endosomes and lysosomes for ligand 
processing and receptor degradation or recycling. Over the past 15 years, the molecular 
analysis of rare inherited diseases identified defective receptor-mediated endocytosis as a 
major mechanism of renal Fanconi syndrome (18-20). Selective proteinuria and 
manifestations of proximal tubule dysfynction are detected in patients and corresponding 
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mouse models with inactivating mutations in LRP2 coding for megalin (Donnai-Barrow 
syndrome) (21), in CUBN coding for cubilin or AMN coding for amnionless (Imerslund-
Gräsbeck syndrome) (22), and the CLCN5 gene coding for the endosomal exchanger ClC-5 
(Dent’s disease) (20). Despite evidence of proximal tubule dysfunction and renal Fanconi 
syndrome, the potential involvement of megalin and cubilin in the pathogenesis of NC has 
been questioned (5), relying on expression studies in renal biopsies (8) and clonal cells 
derived from the urine (6). 
Based on several lines of evidence, our studies demonstrate that receptor-mediated 
endocytosis is involved in the proximal tubule dysfunction associated with cystinosis. 
Detailed metabolic studies performed every 4 weeks allowed us to establish the time-course 
of tubular dysfunction in the Ctns-/- mice. These mice show progressive manifestations of 
renal Fanconi syndrome (LMW proteinuria including albumin and specific ligands of megalin 
and cubilin, phosphate and glucose) from 12 weeks to 20 weeks, in absence of renal failure or 
major histology lesions. The fact that less than 5% of nephrons show swan-neck lesions in the 
S1 segment at this stage indicate that the urinary loss of solutes is not caused by a loss of 
tubular functional mass but rather by a specific mechanism causing dysfunction of apparently 
intact cells. The mechanism of the transport defect associated with cystinosis was further 
investigated by using the well-established primary cultures of proximal tubule cells obtained 
from Ctns-/- kidneys. When grown on filters, these cells polarize and keep their differentiation 
as shown by morphological features and specific transport processes (11). The primary 
cultures are obtained from defined proximal tubule segments, at very precise stages of disease 
and with perfectly matched control cells from littermates. The primary cells are particularly 
well-suited to investigate receptor-mediated endocytosis and lysosomal processing, and we 
recently used such cells to substantiate the tubular dysfunction of mice KO for megalin (12) 
and ClC-5 (23), two models that are directly relevant for nephropathic cystinosis.  
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 Analyses of proximal tubule cells obtained from Ctns-/- kidneys reveal that their 
functional defect includes both defective endocytosis and impaired lysosomal processing. 
These changes are caused by a selective decrease in the expression of megalin and cubilin as 
well as cystine accumulation leading to enlarged, perinuclear lysosomes. The lysosomal 
defect is evidenced by the strong decrease in cathepsin B activity revealed by FRAP analysis. 
Importantly, the proximal tubule phenotype of the Ctns-/- mice includes the urinary loss of 
cathepsin B, as was already observed for the Clcn5-/- mice that mimick Dent's disease (24).  
Of note, these defects do not involve endosome catalysts (Rab5a) and components of the 
brush border membrane (CD13), nor the lysosome-associated proteins LAMP1 and LAMP2 
(data not shown). The endocytic defect in nephropathic cystinosis is thus very similar to that 
encountered in Dent's disease (25), indicating that the functional loss of an endosomal 
chloride-proton exchanger (ClC-5) or of a lysosomal transporter (cystinosin) may have the 
same functional consequences on the endolysosomal compartment in proximal tubule cells.   
In addition to receptor-mediated endocytosis, a second distinct pathway operating at 
the apical border of proximal tubule cells appears to be defective in this cystinosis model. 
Indeed, Ctns-/- mice show phosphaturia and a decreased expression of NaPi-IIa (SLC34A1) 
cotransporter in proximal tubule cells. It must be noted that LMW proteinuria occurs at least 4 
weeks before phosphaturia in the Ctns-/- mice. Since phosphate reabsorption via NaPi-IIa is 
under the control of the parathyroid hormone (PTH) via its receptors (PTHR) located on the 
apical and basolateral poles of the cells, one can hypothesize that a trafficking defect similar 
to that observed in Clcn5-/- kidneys ex vivo (24) and in vivo (26) may be involved.  
Our previous studies have shown that transcription factors play an important role in 
the phenotypic changes observed in proximal tubule cells in various types of renal Fanconi 
syndromes (13,14,27). In particular, the Y-box transcription factor zonula occludens 1 (ZO-
1)-associated nucleic acid binding protein (ZONAB) promotes cell proliferation (by inducing 
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the expression of the proliferating factors PCNA and cyclin D1) but directly represses 
megalin/cubilin expression in proximal tubule cells (14). Our data show that the mRNA 
expression of megalin/cubulin is decreased in Ctns-/- kidneys and primary cultured cells, 
whereas the nuclear expression of ZONAB is increased. Furthermore, PCNA and cyclin D1, 
which are direct targets of ZONAB, are also increased. The Ctns-/- cells are consistently 
hyperproliferative, whereas additional markers of dedifferentiation are strongly increased. 
These data suggest that the loss of cystinosin is associated with a switch between 
differentiation and proliferation, which may involve a specific transcriptional cascade in 
proximal tubule cells. Dedifferentiation would be reflected by decreased expression of 
megalin/cubilin, causing defective endocytosis and LMW proteinuria. Alternatively, the 
switch towards proliferation could involve the loss of lysosomal function. It is known that 
retention inside the endo-lysosomal compartment with subsequent prolonged activation of the 
EGF-receptor may cause dedifferentiation in renal proximal tubule cells (28). 
 In summary, our data reveal that the loss of cystinosin function in proximal tubule 
cells triggers an abnormal transcription program with profound defects in the endo-lysosomal 
pathway leading to the urinary loss of specific ligands, before structural damage or renal 
failure. Insights in the early manifestations of nephropathic cystinosis may offer new targets 
for intervention, before irreversible renal damage.  
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MATERIALS AND METHODS 
Transgenic mice. All experiments were conducted conducted on age- and gender-matched 
Ctns+/+ and Ctns-/- littermates (C57BL/6 background) (10). The mice had free access to 
appropriate standard diet (Carfil Quality, Oud-Turnhout, Belgium). All procedures were 
performed in accordance with National Institutes of Health guidelines for the care and use of 
laboratory animals and with the approval of the Committee for Animal Rights of the UCL 
Medical School (Brussels, Belgium) and the University of Zurich (Zurich, Switzerland). 
 
Renal function parameters. After genotyping at 6 weeks, mice were trained and kept once 
weekly in metabolic cages (overnight) with ad libitum access to food and drinking water. The 
urine was collected over ice and diuresis was measured. Blood (intracardiac puncture) and 
kidneys were obtained after anesthesia with ketamine/xylazine or isoflurane (24,25). The 
urine and blood parameters were measured using a Synchron CX5 analyzer (Beckman 
Coulter, Fullerton, CA), whereas Clara cell protein (CC16) concentration was measured in 
duplicate by latex immunoassay (courtesy of X. Dumont, UCL Medical School, Brussels). 
Urinary LMW proteins, including vitamin D binding protein and transferrin were measured 
by western blotting as described previously (24,25,29,30). 
 
Histological studies. Kidneys from the Ctns mice were rapidly dissected, rinsed in ice-cold 
PBS, fixed in 4% paraformaldehyde in 0.1M phosphate buffer for 6 h, and embedded in 
paraffin. Sections were deparaffinized with xylene and rehydrated with descending ethanol 
into PBS, then stained with hematoxylin and eosin analyzed and photographed with an 
Axioplan2 microscope (Carl Zeiss, Zaventem, Belgium) and anAxioCamcamera (Carl Zeiss). 
Sections were read by a renal pathologist blinded to the animal group. For ultrastructural 
15 
 
examination, kidney samples were fixed with 4% glutaraldehyde in PBS at 4°C for 2 hours. 
After washing with 0.1 M PBS, samples were post-fixed with 1% osmium tetroxide, 
dehydrated, and embedded in araldite. Ultrathin sections were examined with a JEOL 1010 
transmission electron microscope (JEOL, Tokyo, Japan) after uranyl acetate and lead citrate 
staining. 
 
Antibodies. The following antibodies were used in this study: mouse anti-rat PCNA (Dako, 
Glostrup, Denmark), rabbit anti-human DBP (Dako), rabbit anti-human LMW proteins 
(Dako), rabbit anti-human CC16 (BioVendor, Heidelberg, Germany), rabbit anti-human 
transferrin (Dako); goat anti-mouse cathepsin B/D (R&D, Minneapolis, USA); mouse anti- β-
actin (Sigma, St. Louis, USA); rabbit anti-human ZO1 (Invitrogen, Life Technologies, Zug, 
Switzerland); rabbit anti-mouse and anti-human ZONAB (Invitrogen; Bethyl Lab, 
Montgomery, USA), rabbit anti-human AQP1 (Millipore, Billerica, USA), rabbit anti-human 
CD13 (Abcam, Cambridge, UK), mouse anti-human  nuclear matrix protein p84 (Abcam), 
rabbit anti-NaPi-IIa (gift from C. A. Wagner, University of Zurich, Zurich), rabbit anti-mouse 
Rab5a (Sigma), rabbit anti-rat LAMP1 (Abcam), rabbit anti-rat LAMP2 (Abcam). Sheep anti-
megalin and rabbit anti-cubilin were kindly provided by Dr. P. Verroust, INSERM, Paris, 
France. 
 
Isolation and primary cultures of proximal tubule cells. Primary cultures of mouse 
proximal tubule cells were prepared from gender-matched Ctns+/+ and Ctns-/- mice aged of 20 
weeks las described previously (11). For the isolation of proximal tubule cells, proximal 
tubule segments were seeded onto collagen-coated PTFE filter membranes (0.33cm², pore 
size 0.4 µm, Transwell-COL, Costar, Corning Inc., USA) in culture medium 
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(DMEM:F12 with 15mM HEPES, 0.55mM Na-pyruvate, 0.1ml/l non-essential amino acids 
and the SingleQuots® Kit (Lonza, Verviers, Belgium) containing hydrocortisone, hEGF, 
FBS, epinephrine, insulin, triiodothyronine, transferrin, gentamicin/amphotericin, pH 7.40, 
325mOsm/kg) and incubated in a humidified chamber at 37°C – 5% CO2. The medium was 
replaced every 48 h. Confluent monolayers of proximal tubule cells expanded from the 
tubular fragments after 6–7 days. All experiments were performed on non-passaged, confluent 
monolayers grown on collagen-coated filters. 
 
Quantitative real-time PCR. Total RNA was extracted from kidneys using AurumTM Total 
RNA Fatty and Fibrous Tissue Kit (Bio-Rad, Hercules, CA), following the manufacturer’s 
protocol. DNAse I treatment was performed to eliminate genomic DNA contamination. Total 
RNA was extracted from primary cell cultures with RNAqueousR kit (Applied Biosystems, 
Life Technologies), following the manufacturer’s protocol. One microgram of RNA was used 
to perform the reverse transcriptase reaction with iScriptTM cDNA Synthesis Kit (Bio-Rad). 
The primers were designed using Beacon Designer 2.0 (Premier Biosoft International, Palo 
Alto, USA). Changes in target genes mRNA levels were determined by quantitative RT-PCR 
with an iCycler IQ System (Bio-Rad) using SYBR Green I detection of single PCR product 
accumulation. The qRT-PCR analyses were performed in duplicate with 100nM of both sense 
and anti-sense primers in a final volume of 20µl using iQTM SYBR Green Supermix (Bio-
Rad). PCR conditions were 94°C for 3 min followed by 40 cycles of 30 sec at 95°C, 30 sec at 
61°C and 1 min at 72°C. The relative changes in target gene/GAPDH mRNA ratio were 
determined by the relation 2-ΔΔCt  (31). 
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Western Blotting. Protocol used for immunoblotting has been described previously (29,30). 
Proteins were extracted from isolated kidneys or primary cultured cells, lysed in lysis buffer 
containing protease inhibitors (Complete MiniR, Roche Diagnostics, Belgium), followed by 
sonication and centrifugation at 16 000 g for 1 min at 4°C. Tissue, cell and urine samples 
were thawed on ice, normalized for protein (20 g/lane) or urinary creatinine levels, diluted 
in Laemmli buffer and separated by SDS-PAGE in reducing conditions. After blotting onto 
nitrocellulose and blocking, membranes were incubated overnight at 4°C with primary 
antibody, washed, incubated with peroxidase-labeled secondary antibody, and visualized with 
enhanced chemiluminescence (ECL Pierce). For reprobing, the membranes were rinsed, 
incubated for 30 minutes at 55°C in a stripping buffer (62.5 mmol/L Tris-HCl, 2% SDS, 100 
mM - mercaptoethanol, pH 7.4), before incubation with primary antibodies. Quantitative 
analysis was performed by scanning the blots and measuring the relative density of each band 
normalized to β-actin using NIH-Image V1–57 software. 
 
Immunofluorescence and confocal imaging. Mouse kidneys were snap-frozen in cryogenic 
Tissue-Tek OCT compound (Electron Microscopy Sciences, Hatfield, USA). The embedded 
tissue was sectioned at 6 mm with a Leica Kryostat (Leica, Heerbrugg, Switzerland). The 
sections were fixed with 4% paraformaldehyde, blocked with PBS containing 5% BSA, and 
incubated for 1 h with primary antibodies. After three PBS rinses, fluorophore-conjugated 
Alexa secondary antibodies (Invitrogen) were applied for 30 min. Sections were subsequently 
mounted in Prolong Gold Anti-fade reagent (Invitrogen) and then analysed under a Zeiss 
LSM510Meta Confocal microscope (Carl Zeiss).  
The cells were fixed for 10 min with 4% paraformaldehyde (Sigma) in PBS, quenched with 
50mM NH4Cl and permeabilized for 30 min in blocking buffer (0.1% (w/v) Triton X-100, 
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0.5% (w/v) BSA in PBS/Ca/Mg). The cells were incubated for 2 h with the primary antibody, 
washed three times in PBS, incubated for 1 h with the secondary (Alexa labelled) antibody, 
washed three times in PBS and were finally taken on Vectashield-mounted coverslips. The 
samples were examined under a Zeiss LSM 510 confocal laser-scanning microscope (Carl 
Zeiss) equipped with x63 oil-immersion objective. Image processing was done with Adobe 
Photoshop C2 (Adobe Sysytem Inc., San Jose, USA). To perform quantitative image analysis, 
10–15 randomly chosen fields that included 8–10 cells each were scanned, using the same 
setting parameters (i.e., pinhole, laser power, offset gain and detector amplification) below 
pixel saturation. The mean intensity per cell was determined using the histogram function in 
the Zeiss LSM 510 Software (version 3.2), and all of the pixel values above background 
levels were quantified. All of the experiments were repeated at least three times, and 
representative images are shown. Quantification of number and the size of LAMP1, LAMP2 
and cathepsin D positive vesicles were performed using the AnalySIS software (Soft Imaging 
Systems GmbH, Muenster, Germany). Quantification was carried out on at least 20 cells per 
condition from two to four independent experiments. 
 
Albumin endocytic uptake. The endocytosis assay was performed as described previously 
(23). Monolayers of proximal tubule cells were washed with warm Hank’s balanced salt 
solution (HBSS without phenol red with 10mM glucose, 5mM glycine, 1mM alanine, 15mM 
HEPES, final pH to 7.40 with TRIS base and osmolality to 325 mOsm/kg with mannitol) after 
which they were incubated with 0.5mg/ml FITC- BSA for 15 min at 37°C. After the 
incubation, primary cultures were washed 6 times with cold HBSS (4°C) and lysed in lysis 
buffer (1mM EDTA, 20mM imidazole pH 7.2 and 250mM sucrose). The fluorescence in the 
lysate was measured in a single-beam fluorimeter (PerkinElmer, Santa Clara, USA) at an 
excitation wavelength of 490±10nm and emission wavelength at 520±10nm. Fluorescence 
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was normalized for the amount of proteins in the primary cell cultures measured using the 
bicinchoninic acid protein assay (Pierce, Aalst, Belgium). 
For live-cell imaging, confluent monolayers of mPTC were incubated with 0.5mg/ml FITC-
conjugated BSA for 7 min at 37°C and washed.  Fluorescence was chased up to 45 min after 
exposure of the cells to albumin. Cells were examined using the Zeiss LSM510Meta Confocal 
microscope (Carl Zeiss, Belgium). 
 
Quantification of lysosome distribution. To score lysosome distribution, cells were 
categorized into perinuclear-dominant lysosomal pattern (more than 50% of LAMP1 positive 
vesicles localized in the perinuclear region) and peripheral-dominant pattern (more than 50% 
of the vesicles localized in the peripheral region), on the basis of the number of lysosomes in 
each region. Quantification is based on at least three independent experiments, each carried 
out in triplicate, and 100 cells were counted in each slide; the scorer was blinded to treatment. 
The data are expressed as a proportion of cells with predominantly (>50%) perinuclear 
lysosomes. 
 
Fluorescence recovery after photo-bleaching (FRAP) assay for cathepsin B activity. The 
lysosomal cathepsin B activity was measured in primary cultures of proximal tubule cells 
using the membrane-permeable Magic RedTM tracer coupled to FRAP assay. The primary 
cells were transferred to a physiological imaging buffer (NaCl 130 mM, KCl 5 mM, CaCl2 2.5 
mM, MgCl2 2.5 mM, HEPES 25mM) containing the Magic Red cathepsin B peptide (AbD 
Serotec, Oxford, UK) added to the medium at 1:10 dilution and incubated at 37°C.  Live cell 
imaging and fluorescence recovery analysis were done using LSM510 Zeiss confocal 
microscope. To achieve photo-bleaching of individual Magic Red-positive lysosomes, areas 
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of interest were drawn around selected spots, and movie acquisition was started. Sixty 
seconds later, the spots were photobleached using 458, 488, 543, and 633 nm lasers with a 
63x objective. Approximately 5 to 8 cells per field of view were bleached for a duration of 
100 bleaching cycles according to the bleaching module within LSM510 software (LSM 510 
version 3.2). The recovery of fluorescence was monitored over time (400s) by scanning the 
bleached area at the conventional (low) laser power to minimize photo bleaching during 
sampling. To analyze the rate of recovery, we compared the fluorescence of the 
photobleached area to that of an adjacent unbleached area of the same cell with similar 
fluorescence intensity. For each time point, the fluorescence of the bleached area was 
normalized to that of corresponding control (unbleached) area to correct for possible drift of 
the focal plane or photo-bleaching incurred during the low light sampling. Quantification of 
fluorescence was carried out using Volocity software, with each data set having 
approximately 25 cells in each condition analyzed, and each curve representing results from 3 
experiments. For each experimental FRAP curve, the τ1/2 value was calculated by fitting the 
data with Boltzmann function. The FRAP experiments were performed at 37°C on Zeiss 
LSM510 microscope equipped with Zeiss confocal scanning laser using a x63 1.4 numerical 
aperture objective. The specificity of tracer was verified by incubating primary cultured cells 
with 100 µM leupeptin (Calbiochem, Merck Millipore, Billerica, USA) dissolved in DMSO 
(vehicle) for 9h before exposing them to Magic Red (32).  
 
Cystine  measurement. The cystine assay was performed as previously described (33). 
Briefly, dissected tissues or primary cultured cells were homogenized and lysed in the 
presence of N-ethylmaleide to avoid interference from cysteine. Protein was determined on 
the pellet using Lowry method (33). After deproteinization, addition of stable isotope d6 
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cystine and butylation, cystine was measured by liquid chromatography-tandem mass 
spectrometry using an API 3000 mass spectrometer (Applied Biosystems, Life Technologies). 
 
Cell proliferation. Primary cultures of PTE cells were incubated at day 1, 3, 5, 6, 7 and 8 
with BrdU (BrdU Cell Proliferation ELISA Kit, Abcam) for 24 h at 37°C. The cells were then 
fixed and  permeabilized, and DNA was denatured. The detector anti-BrdU monoclonal 
antibody was added for 1 h and then washed away. A secondary  horseradish peroxidase-
conjugated goat anti-mouse antibody was added which catalyzed the conversion of the 
chromogenic substrate and the colored reaction product was quantified using a Benchmark 
Plus microplate spectrophotometer (Bio-Rad). 
 
Statistical analysis. Data were expressed as mean ± SEM. Significance of differences was 
assessed by unpaired Student t test. P values < 0.05 were considered statistically significant. 
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LEGENDS TO FIGURE  
Figure 1: Ctns mouse model : progression of renal phenotype. 
A. Growth retardation and evolution of proximal tubule dysfunction in Ctns-/- mice. From 12 
weeks of age (blue bars),  Ctns-/- mice present a trend for lower body weight than wild-type 
littermates, as well as increased urinary excretion of Clara cell protein (CC16), indicative of 
low molecular weight proteinuria in absence of renal failure (BUN and creatinine clearance).  
At age 18 weeks (green bars), Ctns-/- mice  show significant growth retardation, with an 
increased urinary excretion of glucose, phosphate and albumin. At 24 weeks of age (red bars), 
Ctns-/- mice  show a complete renal Fanconi syndrome, in absence of signs of renal failure. 
All values are expressed as % of wild-type, matched for age and gender (*p<0.05; **p<0.01; 
***p<0.001). Ten pairs of Ctns mice were examined at each time point. 
B. Urinary excretion of low molecular weight proteins (LMWP), vitamin D-binding protein 
(DBP), transferrin (TF) and procathepsin B (CtsB) in 24-week old Ctns mice. Urine samples 
were loaded on 7.5% PAGE, blotted to nitrocellulose, and incubated with appropriate primary 
antibodies. Loading was normalized to urinary creatinine concentration. A major increase in 
urinary excretion of LMWP, DBP, TF and CtsB is detected in Ctns-/- mice. 
C. Staining with periodic acid Shiff and hematoxylin on Ctns kidney sections obtained at 24 
weeks of age. The Ctns-/- kidneys (b, c, d) show the typical swan neck lesions (b, c) in less 
than 5% of nephrons. Otherwise, the renal parenchyma of Ctns-/-  mice is normal. Electron 
microscopy of kidney cortex in 24-week old Ctns-/- mouse (e, f) reveals lysosomal 
accumulation of cystine crystals of various sizes in proximal tubule cells (arrow). High 
magnification of a proximal tubule cell shows the intralysosomal accumulation of cystine 
crystals (arrow). Scale bar: 200µm (a, b); 50µm (c, d); 0.5µm (e); 5µm (f). 
D. Cystine levels assay in kidney cortex from 24-week old Ctns mice. A major increase in the 
cystine levels is observed in Ctns-/- vs. Ctns+/+ kidneys (57.3 ± 2.8 vs. 0.54 ± 0.04 nmol 1/2 
cystine/mg protein, n=4 pairs, ***p<0.001). 
 
Figure 2: Ctns kidneys: expression of endocytic markers. 
A. Quantitative RT-PCR to measure the mRNA expression of proximal tubule genes (Aqp1, 
Lrp2, Cubn, Clcn5, Sglt2, Sglt1, Slc34a1 and Atp6v1e1) mRNA in 24-week old, whole Ctns 
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kidneys (n=7 pairs). A decreased expression of Lrp2 (megalin), Cubn (cubilin), Sglt2 
(SGLT2) and Slc34a1 (NaPi-IIa) mRNA is observed in Ctns-/- kidneys vs. Ctns+/+ controls 
(taken as 100%, dotted line). The mRNA expression of target genes was normalized to the 
normalization factor calculated from 4 different housekeeping genes. Values are expressed as 
mean  ± SEM, *p<0.05. 
B. Representative immunoblotting and densitometry analysis for proximal tubule markers 
megalin, cubilin, NaPi-IIa, AQP1, Rab5a and CD13 in 24-week Ctns kidneys (n=4 pairs). 
Equal amount of protein extracts (20µg) were run on SDS-PAGE, transferred to nitrocellulose 
and probed with appropriate antibodies. Membranes were stripped and reincubated for β-
actin. The expression of megalin, cubilin and NaPi-IIa is reduced in Ctns-/- extracts, whereas 
the expression of AQP1, Rab5a and CD13 is unchanged vs. Ctns+/+. Densitometry values are 
expressed as mean ± SEM, *p<0.01; ** p<0.001; *** p<0.0001. 
C. Immunofluorescence staining for megalin (a, b), cubilin (c, d), NaPi-IIa (e, f) and AQP1 
(g, h) in Ctns+/+ (a, c, e, g) and Ctns-/- (b, d, f, h) kidneys from 24-week old mice. The signal 
for megalin, cubilin and NaPi-IIa is strongly reduced in the proximal tubule of Ctns-/- kidneys, 
whereas staining for AQP1 is unchanged. Scale bar: 50µm. 
 
Figure 3: Defective endocytosis in proximal tubule cells from Ctns-/- kidneys. 
A. Confluent monolayers of primary cultures of proximal tubule cells obtained from 20-week 
old Ctns kidneys were incubated with 0.5mg/ml Alexa488-conjugated BSA for 1h at 4°C, 
followed by 15 min incubation with growth medium at 37°C. A decreased uptake of 
Alexa488-BSA is observed in Ctns-/- cells compared to control cells (left panel; scale bar: 
10µm). The uptake of Alexa488-BSA was quantified in a single-beam fluorimeter (right 
panel), confirming the major decrease in proximal tubule cells from Ctns-/- vs. Ctns+/+ (23.5 ± 
5.0 vs. 74.7 ± 7.2 ng/µg protein.15min, respectively, **p<0.01).  
B. Quantitative RT-PCR to assess the expression of proximal tubule markers in primary 
cultures of proximal tubule cells obtained from 20-week old Ctns-/- kidneys (compared to 
levels in Ctns+/+ cells taken as 100%). The mRNA expression of target genes was normalized 
to Gapdh. The Ctns-/- cells show a decreased expression of Lrp2, Slc34a1, Cubn, Sglt2 mRNA 
vs.  Ctns+/+ cells. Values are expressed as mean ± SEM, *p<0.05 (n = 6 pairs). 
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C. Immunoblotting and densitometry analysis for megalin, cubilin and NaPi-IIa in primary 
cultures of proximal tubule cells from Ctns+/+ vs Ctns-/- kidneys. Equal amounts of proteins 
(15µg) from cell cultures (6 wells/sample) were loaded on each lane. The expression of 
megalin, cubilin and NaPi-IIa is decreased in Ctns-/- cells compared to wild-type. Values are 
expressed as mean ± SEM, **p<0.01; *** p<0.001. 
D. Monolayers of proximal tubule cells from Ctns+/+ and Ctns-/- kidneys were labeled with 
antibodies against megalin (green, left panel) and against cubulin (red, right panel). Confocal 
microscopy images (upper panels) and X-Z side view of a z-stack (bottom panels) reveal a 
decreased expression of megalin and cubulin at the apical plasma membrane in Ctns-/- 
proximal tubule cells compared to wild-type cells. Nuclei counterstained with DAPI (blue). 
Scale bar, 10 μm. 
 
Figure 4: Lysosomal dynamic and degradative capacity are altered in proximal tubule cells 
from Ctns-/- kidneys.  
A. Intracellular cystine assay in primary culture of proximal tubule cells isolated from 20-
week old Ctns kidneys (N=6 samples). A major increase in intracellular cystine levels is 
observed in Ctns-/- cells vs. controls  (78.7 ± 13.9 vs. 5.1 ± 1.4 nmol 1/2 cystine/mg protein, 
respectively, n=4 pairs of samples, ***p<0.001).  
B. Primary cultured proximal tubule cells from Ctns kidneys were labeled with antibodies 
against plasma membrane and lysosome markers in order to evaluate the steady state 
distribution of LAMP1, LAMP2 and cathepsin D (CtsD). Representative images of Ctns-/- 
proximal tubule cells show a significant decrease in the number and an increase in the size of 
LAMP1-, LAMP2- and CtsD-positive vesicles, in comparison with Ctns+/+ cells.  Nuclei 
counterstained with DAPI (blue). Scale bar, 10 μm.  
C-E. The cells from (B) were assessed in a blind fashion for (C) change in number and size of 
LAMP1, LAMP2 and CtsD-positive vesicles, for (D) presence of enlarged lysosomes; and for 
(E) change in vesicle positioning. Values are expressed as mean ± SEM (n=50 cells; three 
independent experiments; ***p<0.001 (number) and **p<0.01 (size); ***p<0.001 (enlarged 
lysosomes) and **p<0.01 (positioning)).  
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F. Fluorescence Recovery After Photo-bleaching (FRAP) assay of cathepsin B activity. Time-
lapse of photo-bleaching and fluorescence recovery of Magic Red-positive lysosomes in 
primary proximal tubule cells from Ctns +/+(upper panels) and Ctns-/- (lower panels) cells. 
Representative images, with time intervals indicated in seconds. Right panel: FRAP analysis 
of Magic Red- positive lysosomes from  Ctns -/- and Ctns+/+ proximal tubule cells. The FRAP 
data are displayed as percentage of recovery with respect to the fluorescence before 
bleach(100%) and are representative of 10 recordings from different cells. The fluorescence 
recovery is significantly attenuated in Ctns-/- cells as compared to control Ctns+/+ cells (τ1/2,  
time for exchanging half of the mobile Magic Red fraction between bleached and unbleached 
areas: 68 ± 3.5 vs. 47 ± 2.9 sec, respectively, p<0.05).  
G. Validation of the Magic Red-cathepsin B assay. Representative image of treatment with 
100 µM leupeptin (in DMSO) on Ctns+/+ proximal tubule cells exposed to Magic Red-
cathepsin B:  a decreased degradation capacity of lysosomes is obseerved in Ctns+/+ cells 
exposed to leupeptin compared to DMSO alone. Scale bar, 10 μm. Right panel: quantification 
of cell-associated Magic Red vesicles, evaluated as mean fluorescence intensities per cell and 
expressed in arbitrary units (a.u.; n=50 cells; three independent experiments, **p<0.001). 
 
Figure 5: Ctns-/- kidneys: dedifferentiation and proliferation. 
A. Quantitative RT-PCR analysis of the expression of the proliferation markers Pcna (PCNA) 
and Ccnd1 (Cyclin D1) and the transcription factors Nrf2 (NRF2) and DbpA (ZONAB) 
mRNA in whole kidneys, obtained from 24-week old Ctns mice (n=7 pairs). The Ctns-/- 
kidneys show an increased expression of PCNA, CyclinD1, and NRF2 in comparison with 
Ctns+/+ samples (*p<0.05). 
B. Upper panels: Double immunofluorescence staining for PCNA and AQP1 in 24-week old 
Ctns kidneys. An increased nuclear expression of PCNA is observed in the AQP1-positive 
proximal tubule cells of Ctns-/- kidneys, demonstrating an increased cellular proliferation. 
Lower panels: Immunofluorescence for ZONAB and AQP1 in 24-week old Ctns kidneys. In 
comparison with wild-type tissue, Ctns-/- kidneys show a nuclear cocnentration of ZONAB in 
AQP1-positive proximal tubule cells. G, glomeruli (AQP1 in erythrocytes). Scale bar 50µm. 
C. Representative immunoblotting of nuclear extracts from 24-week old Ctns kidneys  
showing increased expression of ZONAB and PCNA in nuclei from Ctns-/- kidneys. Loading 
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control was performed after membrane stripping and incubation with monoclonal antibody 
against nuclear matrix protein p84. Values are expressed as mean ± SEM on 4 pairs of 
samples. (*p<0.05; ** p<0.01). 
 
Figure 6: Proliferation and dedifferentiation in proximal tubule cells from Ctns-/- kidneys. 
A. Time-course of BrdU incorporation in primary cultures of proximal tubule cells obtained 
from Ctns kidneys. Increased cell proliferation was detected in Ctns-/- vs. wild-type cells at 
each time point. Values are expressed as mean ± SEM, n=4 pairs of samples. *p<0.05, 
**p<0.01, ***p<0.001. 
B. Immunofluorescence for ZONAB in primary cultures of proximal tubule cells from Ctns 
kidneys. Left panels: Representative images showing nuclear translocation of ZONAB in 
Ctns-/- cells compared to diffuse cytoplasmic staining in Ctns+/+ cells. Nuclei counterstained 
with DAPI (blue). Scale bar, 10 μm. Right panels: Quantification of the number of cells with 
nuclear ZONAB. (n=50 cells; three independent experiments, ***p<0.001). 
C. Immunoblotting and quantification for ZONAB and PCNA in primary cultured proximal 
tubule cells obtained from Ctns+/+ and Ctns-/- kidneys. Equal amounts of proteins (15µg) from 
nuclear extracts (6 wells/sample) were loaded in each lane. The expression of ZONAB and 
PCNA is increased in Ctns-/- cells, compared to Ctns+/+ cells. Values are expressed as mean ± 
SEM, *p<0.05; ** p<0.01. 
D. Immunofluorescence for the tight junction protein ZO1 in primary cultures of proximal 
tubule cells obtained from Ctns kidneys. Left panels: The steady state distribution of ZO1 is 
altered in Ctns-/- vs. wild-type Ctns+/+ cells. Nuclei counterstained with DAPI (blue). Scale 
bar, 10 μm. Right panel: Quantification of cell-associated ZO1, evaluated as mean 
fluorescence intensity per cell and expressed in arbitrary units (a.u.; n=50 cells; three 
independent experiments, ***p<0.001). 
E. Immunoblotting and quantification of ZO1 in proximal tubule cells from Ctns kidneys. 
Equal amounts of proteins (15µg) from 7-day-old primary cultured cells (6 wells/sample) 
were loaded on SDS-PAGE, transferred to nitrocellulose and probed with anti- ZO1 
antibodies. Loading was normalized for β-actin. The expression of ZO1 is decreased in Ctns-/- 
cells, compared to wild-type cells. Values are expressed as mean ± SEM, **p<0.01. 
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F. Short-circuit current (Isc) and transepithelial resistance (Rt) measured simultaneously on 7-
day-old monolayers of primary cultured proximal tubule cells (n = 5) isolated from 20-week 
Ctns+/+ (white bar) and Ctns-/- (black bar) mice. A strong reduction in Isc (5.4 ± 0.76 vs. 14.2 ± 
0.63 µA/cm2) and Rt (26.2 ± 2.3 vs. 58.4 ± 2.7 Ω/cm2) is observed in Ctns-/- vs. Ctns+/+ cells. 
**p<0.01; *** p<0.001. 
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Table I. Body weight, plasma and urine parameters in the Ctns mice. 
 
Footnote Table 1: *p<0.05; **p<0.01; *** p<0.001  
 Body 
weight 
(g) 
Urine 
volume 
(µl/24h) 
GFR 
(µl/min/g BW) 
Urinary 
albumin 
(µM/mg 
creat/dl) 
Urinary 
CC16 
(µg/g creat) 
Urinary 
Calcium 
(mg/g creat) 
 
Urinary 
phosphate   
 (mg/g creat) 
Urinary 
Glucose 
(mg/g creat) 
Urinary 
creat 
(mg/dl) 
BUN 
(mg/dl) 
Plasma 
Creat 
(mg/dl) 
 
Ctns+/+ (n=10) 
Age : 12weeks 
 
21.7 ± 0.8 
 
891 ± 105 
 
51 ± 9 
 
2746 ± 468 
 
16 ± 6 
 
13 ± 2 
 
65 ± 8 
 
1.5 ± 0.08 
 
56 ± 4 
 
36 ± 1 
 
0.07 ± 0.004 
 
Ctns-/- (n=10) 
Age : 12 weeks 
 
19.6 ± 0.4*** 
 
946 ± 117 
 
50 ± 4 
 
3087 ± 119 
 
117 ± 37** 
 
17 ± 6 
 
77 ± 5 
 
1.5 ± 0.12 
 
53 ± 5 
 
39 ± 2 
 
0.08 ± 0.005 
 
Ctns+/+ (n=10) 
Age : 18 weeks 
 
24.5 ± 06 
 
847 ± 125 
 
50 ± 5 
 
2547 ± 257 
 
13 ± 4 
 
12 ± 4 
 
64 ± 6 
 
1.3 ± 0.03 
 
57 ± 3 
 
38 ± 5 
 
0.08 ± 0.001 
 
Ctns-/- (n=10) 
Age : 18 weeks 
 
20.8 ± 0.2*** 
 
935 ± 109 
 
51 ± 2 
 
3157 ± 287** 
 
309 ± 85*** 
 
15 ± 3 
 
207 ± 11*** 
 
28 ± 5c 
 
55 ± 6 
 
32 ± 2 
 
0.08 ± 0.002 
 
Ctns+/+ (n=10) 
Age : 24 weeks 
 
27.5 ± 0.9 
 
840 ± 100 
 
50 ± 7 
 
2464 ± 250 
 
9 ± 2 
 
10 ± 1 
 
68 ± 3 
 
1.4 ± 0.05 
 
61 ± 5 
 
38 ± 2 
 
0.08 ± 0.004 
 
Ctns-/- (n=10) 
Age : 24 weeks 
 
22.6 ± 0.7** 
 
1570 ± 105* 
 
49 ± 3 
 
4970 ± 543*** 
 
986 ± 202*** 
 
11 ± 3 
 
398 ± 27*** 
 
49 ± 10*** 
 
51 ± 3 
 
39 ± 3 
 
0.08 ± 0.003 
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Table 2: Primers used for quantitative RT-PCR analyses. 
Gene 
product 
Forward primer (5’-3’) Reverse primer (5’-3’) PCR 
Product (bp) 
 
Efficiency 
     
Aqp1 GCTGTCATGTACATCATCGCCCAG 
 
AGGTCATTGCGGCCAAGTGAAT 
 
107 0.99 ± 0.02 
Hspa1a ACCACCTACTCGGACAACCA 
 
CGAAGGTCACCTCGATCTGT 
 
151 1.02 ± 0.03 
Car3 TGACCCTGGCTCTGCTAAGA 
 
AGCCCCAGTGAAGATGGAAT 
 
178 1.01 0.02 
Atp6v1e1 GGCGCTCAGCGATGCAGATGT CAAGGCGACCTTTCTCAATG  134 1.05 ± 0.01 
Sglt1 GTATGGTATGGTGGCCGATT 
 
AATATCCAGCCCAGCACAAC 
 
157 0.99 ± 0.02 
DbpA AGGACGCGGAGAAGAAAGTT 
 
ACTTGCGTGGGTTGTTTTTC 
 
153 0.96 ± 0.04 
Pcna TTGGAATCCCAGAACAGGAG 
 
ATTGCCAAGCTCTCCACTTG 
 
155 1.00 ± 0.03 
Nrf2 CAGCCAGCTGACCTCCTTAG 
 
TCAATAGTCCCGTCCAGGAG 
 
159 1.02 ± 0.03 
Ccnd1 AGCAGAAGTGCGAAGAGGAG 
 
CAAGGGAATGGTCTCCTTCA 
 
151 1.01 ± 0.03 
Car2 CTTGAAGCACTGCATTCCAT 
 
CACGATCCAGGTCACACATT 
 
154 1.02 ± 0.03 
Hmox1 AAGAGGCTAAGACCGCCTTC 
 
TCTCTGCAGGGGCAGTATCT 
 
153 1.01 ± 0.02 
Sglt2 TTGGGCATCACCATGATTTA 
 
GCTCCCAGGTATTTGTCGAA 
 
164 1.02 ± 0.02 
Cubn TCATTGGCCTCAGACATTCC 
 
CCCAGACCTTCACAAAGCTG 
 
149 1.04 ± 0.02 
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Lrp2 CAGTGGATTGGGTAGCAGGA 
 
GCTTGGGGTCAACAACGATA 
 
150 1.01 ± 0.03 
Slc34a1 CATCACAGAGCCCTTCACAA 
 
TGGCCTCTACCCTGGACATA 
 
161 0.98 ± 0.03 
Clcn5 TGGAGGAGCCAATCCCTGGTGT 
 
AGAAAGCATCGCTCACACTG 
 
156 0.99 ± 0.02 
Ppiase CGTCTCCTTCGAGCTGTTTG CCACCCTGGCACATGAATC 139 1.02 ± 0.02 
Hprt1 ACATTGTGGCCCTCTGTGTG TTATGTCCCCCGTTGACTGA 162 0.99 ± 0.01 
Actb TGCCCATCTATGAGGGCTAC CCCGTTCAGTCAGGATCTTC 102 1.02 ± 0,02 
Gapdh TGCACCACCAACTGCTTAGC 
 
GGATGCAGGGATGGGGGAGA 176 1.04 ± 0.03 
Arbp CTTCATTGTGGGAGCAGACA 
 
TTCTCCAGAGCTGGGTTGTT 
 
150 0.99 ± 0.01 
      
 
 
 
 
 
 
 
